Diabetes decisions — 2006

The Board has denied the veteran's claims for service connection for type II diabetes mellitus and peripheral neuropathy, as secondary to the type II diabetes mellitus. The claim for sinusitis is remanded due to a lack of a VA examination.

The Board denied the veteran's claims for an earlier effective date for PTSD and service connection for diabetes mellitus, retinopathy, and peripheral neuropathy due to Agent Orange exposure.

The Board denied the appellant's claims for an initial rating higher than 40 percent for type 2 diabetes mellitus and service connection for diabetic peripheral neuropathy of the bilateral upper extremities, as secondary to his service-connected diabetes.

The veteran's claims for service connection are being remanded due to the need to determine if he was exposed to Agent Orange while serving on a ship in Vietnam waters, and to obtain his medical records.

The veteran's service-connected disabilities combine to 70 percent, qualifying him for a TDIU. However, the RO needs to obtain a medical opinion regarding his employability based solely on these service-connected conditions.

The Board has granted service connection for the cause of the veteran's death and dismissed the DIC claim under 38 U.S.C.A. § 1318.

The Board has granted a 40 percent disability rating for the veteran's service-connected type II diabetes mellitus, effective from the date of the decision.

The Board has decided to remand the case for additional development, including obtaining private medical records from a doctor who treated the veteran's diabetes mellitus.

The Board has denied the veteran's claims for increased ratings for peripheral neuropathy of the left lower extremity and type II diabetes mellitus, finding that the evidence does not support a higher rating based on current symptoms.

The Board has determined that the veteran's diabetes mellitus, presumed to be due to Agent Orange exposure in service, contributed materially or substantially to his death from metastatic adenocarcinoma. Service connection for the cause of the veteran's death is granted.

The Board has denied the veteran's claims for increased evaluations for his service-connected conditions, including diabetes mellitus and erectile dysfunction. The issues of entitlement to TDIU have also been addressed.

The veteran seeks service connection for diabetes mellitus, Type II, with erectile dysfunction, claiming exposure to Agent Orange during his service in Korea. The Board has determined that further development is needed to determine if the veteran's unit was near the DMZ where Agent Orange was used.

The Board has denied the veteran's claims for service connection for diabetes mellitus and asthma. The decision is pending further action.

The Board has granted service connection for type 2 diabetes mellitus and dismissed the issue of entitlement to a rating in excess of 10 percent for hypertension.

The Board has denied the veteran's claims for service connection for diabetes mellitus, post-traumatic stress disorder, and a skin disorder. The evidence does not support these claims as they are not related to service or any presumptive exposure.

The Board denied the veteran's request to reopen his claim for service connection for diabetes mellitus, finding no new and material evidence presented.

The veteran's diabetes mellitus was initially rated at 20 percent from May 8, 2001 to September 13, 2005. Since then, it has been rated at 40 percent.

The veteran's claim for an increased initial evaluation for conjunctivitis was denied. The RO found that the evidence did not support a higher rating.

The Board has ordered additional development due to errors in a previous medical opinion and the need for further clarification on whether service-connected conditions contributed to the veteran's death.

The Board has reopened the veteran's claim for service connection for diabetes mellitus, including as due to exposure to herbicide agents. The case is now remanded for further development and consideration.